Baicalein inhibits pulmonary carcinogenesis-associated inflammation and interferes with COX-2, MMP-2 and MMP-9 expressions in-vivo

Toxicology and Applied Pharmacology

Volumn 261, Issue 1, 2012, Pages 10-21

  Chandrashekar, Naveenkumar ^a   Selvamani, Asokkumar ^a   Subramanian, Raghunandhakumar ^a   Pandi, Anandakumar ^a   Thiruvengadam, Devaki ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Baicalein; Cyclo oxygenase 2; Cytokine; Lung cancer; Mast cell; Matrix metalloproteinase

Indexed keywords

ALCIAN BLUE; BAICALEIN; BENZO[A]PYRENE; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HYDROPEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TOLONIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CELL MATURATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; ENZYME BLOOD LEVEL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEUKOCYTE DIFFERENTIAL COUNT; LIPID PEROXIDATION; LUNG CANCER; LUNG CARCINOGENESIS; LUNG LAVAGE; LUNG PARENCHYMA; MAST CELL; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BENZO(A)PYRENE; CYCLOOXYGENASE 2; CYTOKINES; DISEASE MODELS, ANIMAL; FLAVANONES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INFLAMMATION; LIPID PEROXIDATION; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

ANIMALIA; MUS;

EID: 84860518210     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.02.004     Document Type: Article

References (58)

1. Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004, 6:203-208.
2. Alberg A.J., Ford J.G., Samet J.M. American College of Chest Physicians. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest 2007, 132:29S-55S.
3. Anandakumar P., Kamaraj S., Jagan S., Ramakrishnan G., Naveenkumar C., Asokkumar S., Devaki T. Capsaicin alleviates the imbalance in xenobiotic metabolizing enzymes and tumor markers during experimental lung tumorigenesis. Mol. Cell. Biochem. 2009, 331:135-143.
4. Anandakumar P., Kamaraj S., Jagan S., Ramakrishnan G., Devaki T. Lysosomal abnormalities during benzo(a)pyrene-induced experimental lung carcinogenesis-defensive role of capsaicin. Fundam. Clin. Pharmacol. 2009, 23:97-103.
5. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 1994, 12:141-179.
6. Balkwill F. Tumor necrosis factor or tumor promoting factor?. Cytokine Growth Factor Rev. 2002, 13:135-141.
7. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
8. Bogdan C. Nitric oxide and the regulation of gene expression. Trends Cell Biol. 2001, 11:66-75.
9. Cederbaum A.I., Cohen G. Microsomal oxidant radical production and ethanol oxidation. Methods Enzymol. 1984, 105:516-522.
10. Conklin K.A. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr. Cancer 2000, 37:1-18.
11. Cook N.C., Samman S. Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources. J. Nutr. Biochem. 1996, 7:66-76.
12. Cortijo J., Cerda-Nicolas M., Serrano A., Bioque G., Estrela J.M., Santangelo F., Esteras A., Llombart-Bosch A., Morcillo E.J. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur. Respir. J. 2001, 17:1228-1235.
13. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
14. Coussens L.M., Raymond W.W., Bergers G., Laig-Webster M., Behrendtsen O., Werb Z., Caughey G.H., Hanahan D. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 1999, 13:1382-1397.
15. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med. 1995, 333:1757-1763.
16. Gasparini G., Longo R., Sarmiento R., Morabito A. Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?. Lancet Oncol. 2003, 4:605-615.
17. Gupta R.A., Dubois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer 2001, 1:11-21.
18. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18:2195-2224.
19. Hays A.M., Srinivasan D., Witten M.L., Carter D.E., Lantz R.C. Arsenic and cigarette smoke synergistically increase DNA oxidation in the lung. Toxicol. Pathol. 2006, 34:396-404.
20. Hsieh C.J., Hall K., Ha T., Li C., Krishnaswamy G., Chi D.S. Baicalein inhibits IL-1beta- and TNF-alpha-induced inflammatory cytokine production from human mast cells via regulation of the NF-kappaB pathway. Clin. Mol. Allergy 2007, 26:5.
21. Hsieh C.J., Hall K., Ha T., Li C., Krishnaswamy G., Chi D.S. Baicalein inhibits IL-1beta- and TNF-alpha-induced inflammatory cytokine production from human mast cells via regulation of the NF-kappaB pathway. Clin. Mol. Allergy 2007, 26:5.
22. Huang W.H., Lee A.R., Chien P.Y. Synthesis of baicalein derivatives as potential anti-aggregator and anti-inflammatory agents. J. Pharm. Pharmacol. 2005, 57:219-225.
23. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 2000, 87:179-183.
24. Jones D.R., Broad R.M., Madrid L.V., Baldwin A.S., Mayo M.W. Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis. Ann. Thorac. Surg. 2000, 70:930-936.
25. Kamaraj S., Anandakumar P., Jagan S., Ramakrishnan G., Devaki T. Modulatory effect of hesperidin on benzo(a)pyrene induced experimental lung carcinogenesis with reference to COX-2, MMP-2 and MMP-9. Eur. J. Pharmacol. 2010, 649:320-327.
26. Kim H.S., Kwack S.L., Lee B.M. Lipid peroxidation and antioxidant enzymes and benzo[a]pyrene-quinones in the blood of rats treated with Benzo[a]pyrene. Chem. Biol. Interact. 2000, 127:139-150.
27. Kim R., Emi M., Tanabe K., Toge T. Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy. Cancer 2004, 101:2491-2502.
28. Konturek P.C., Nikiforuk A., Kania J., Raithel M., Hahn E.G., Muhldorfer S. Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors. Dig. Dis. Sci. 2004, 49:1075-1083.
29. Kosower N.S., Kosower E.M. The glutathione-glutathione disulphide system. Free Radicals in Biology 1976, 57-84. Academic Press, New York. W.A. Pryor (Ed.).
30. Kundu J.K., Surh Y.J. Inflammation: gearing the journey to cancer. Mutat. Res. 2008, 659:15-30.
31. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement using folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
32. Lynch C.C., Matrisian L.M. Matrix metalloproteinases in tumor-host cell communication. Differentiation 2002, 70:561-573.
33. Migliaccio A.R., Rana R.A., Sanchez M., Lorenzini R., Centurione L., Bianchi L., Vannucchi A.M., Migliaccio G., Orkin S.H. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J. Exp. Med. 2003, 197:281-296.
34. Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochem. Biophys. Acta 1979, 582:67-78.
35. Naveenkumar C., Asokkumar S., Raghunandhakumar S., Jagan S., Anandakumar P., Augustine T.A., Kamaraj S., Devaki T. Potent antitumor and antineoplastic efficacy of baicalein on benzo(a)pyrene-induced experimental pulmonary tumorigenesis. Fundam. Clin. Pharmacol. 2011, 10.1111/j.1472-8206.2010.00910.x.
36. Okawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
37. Pantano C., Reynaert N.L., Vliet A.V.D., Janssen-Heininger Y.M.W. Antioxid. Redox Signal. 2006, 8:1791-1806.
38. Philip M., Rowley D.A., Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin. Cancer Biol. 2004, 14:433-439.
39. Rajakrishnan V., Viswanathan P., Menon V.P. Hepatotoxic effect of alcohol on female rats and siblings: effect of n-acetyl cysteine. Hepatol. Res. 1997, 9:37-50.
40. Saijo Y., Tanaka M., Miki M., Usui K., Suzuki T., Maemondo M., Hong X., Tazawa R., Kikuchi T., Matsushima K., Nukiwa T. Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J. Immunol. 2002, 169:469-475.
41. Schottenfeld D., Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J. Clin. 2006, 56:69-83.
42. Schweitzer P., Madamba S., Champagnat J., Siggins G.R. Somatostatin inhibition of hippocampal CA1 pyramidal neurons: mediation by arachidonic acid and its metabolites. J. Neurosci. 1993, 13:2033-2049.
43. Sekiya K., Okuda H. Selective inhibition of platelet lipoxygenase by baicalein. Biochem. Biophys. Res. Commun. 1982, 105:1090-1095.
44. Shieh D.E., Liu L.T., Lin C.C. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res. 2000, 20:2861-2865.
45. Sovak M.A., Bellas R.E., Kim D.W., Zanieski G.I., Rogers A.E., Traish A.M., Sonenshein G.E. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 1997, 100:2952-2960.
46. Stetler-Stevenson W.G. The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg. Oncol. Clin. N. Am. 2001, 10:383-392.
47. Strausz J., Muller-Quernheim J., Steppling H., Ferlinz R. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 1990, 141:124-128.
48. Sullivan P.D. Free radicals of Benzo(a)pyrene and derivatives. Environ. Health Perspect. 1985, 64:283-295.
49. Surh Y.J., Kundu J.K., Na H.K., Lee J.S. Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals. J. Nutr. 2005, 135:2993S-3001S.
50. Suzuki Y., Yoshimaru T., Matsui T., Inoue T., Niide O., Nunomura S., Ra C. Fc epsilon RI signaling of mast cells activates intracellular production of hydrogen peroxide: role in the regulation of calcium signals. J. Immunol. 2003, 171:6119-6127.
51. Tai D.I., Tsai S.L., Chang Y.H., Huang S.N., Chen T.C., Chang K.S., Liaw Y.F. Constitutive activation of nuclear factor-κB in hepatocellular carcinoma. Cancer 2000, 89:2274-2281.
52. Tang W., Eisenbrand G. Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine 1992, 919. Springer-Verlag, Berlin.
53. Tomita M., Matsuzaki Y., Onitsuka T. Effect of mast cells on tumor angiogenesis in lung cancer. Ann. Thorac. Surg. 2000, 69:1686-1690.
54. Voronov E., Shouval D.S., Krelin Y., Cagnano E., Benharroch D., Iwakura Y., Dinarello C.A., Apte R.N. IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2645-2650.
55. Wang J., Yu Y., Hashimoto F., Sakata Y., Fujii M., Hou D.X. Baicalein induces apoptosis through ROS-mediated mitochondrial dysfunction pathway in HL-60 cells. Int. J. Mol. Med. 2004, 14:627-632.
56. Wartenberg M., Budde P., De-Marees M., Grunheck F., Tsang S.Y., Huang Y., Chen Z.Y., Hescheler J., Sauer H. Inhibition of tumor-induced angiogenesis and matrix-metalloproteinase expression in confrontation cultures of embryoid bodies and tumor spheroids by plant ingredients used in traditional Chinese medicine. Lab. Invest. 2003, 83:87-98.
57. Yoshino M., Murakami K. Interaction of iron with polyphenolic compounds: application to antioxidant characterization. Anal. Biochem. 1998, 257:40-44.
58. Yu J.L., Rak J.W. Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res. 2003, 5:83-88.